Advertisement

Purinergic Signalling

, Volume 15, Issue 3, pp 357–366 | Cite as

Multiple adenosine receptor subtypes stimulate wound healing in human EA.hy926 endothelial cells

  • Zeinab Bonyanian
  • Matthew Walker
  • Eugene Du Toit
  • Roselyn B. Rose’MeyerEmail author
Original Article
  • 59 Downloads

Abstract

Wound healing is an important outcome of tissue damage and can be stimulated by adenosine released from cells during events such as tissue injury, ischaemia or tumour growth. The aim of this research was to determine the potency and efficacy of adenosine A1, A2A and A2B receptor agonists on the rate of wound healing and cell proliferation in human EA.hy926 endothelial cells. Real-time PCR data showed that only adenosine A1, A2A and A2B receptor mRNA were expressed in this cell line. All three adenosine receptor agonists, CPA, CGS21680 and NECA, significantly increased the rate of wound healing in human EAhy926 endothelial cells with the following order of potency CGS21680>CPA>NECA and efficacy CPA>NECA>CGS21680. The selective adenosine A1, A2A and A2B receptor antagonists, DPCPX, ZM241385 and MRS1754 (all at 10 nM), reversed the effects of their respective agonists. EAhy926 endothelial cell proliferation was also significantly increased with the adenosine A1 and A2B receptor agonists, CPA and NECA. Western blot analysis demonstrated that adenosine A2A and A1 receptor protein levels were highly expressed compared with the adenosine A2B receptors in the EAhy926 endothelial cell lines. While all three adenosine A1, A2A and A2B receptor subtypes contribute to cell proliferation and wound healing in human EAhy926 endothelial cells, treatments selectively targeting receptor subtypes may further enhance wound healing.

Keywords

Adenosine Endothelial cells Wound healing Cell proliferation 

Notes

Acknowledgements

The EA.hy926 endothelial cell line used for these studies was generously donated to our research group by the Apoptosis Research Group, Griffith University, Gold Coast campus.

Compliance with ethical standards

Conflicts of interest

Zeinab Bonyanian declares that he has no conflict of interest.

Matthew Walker declares that he has no conflict of interest.

Eugene Du Toit declares that he has no conflict of interest.

Roselyn B. Rose’Meyer declares that she has no conflict of interest.

Ethical approval

This article does not contain any studies with human participants or animals performed by any of the authors.

Supplementary material

11302_2019_9668_MOESM1_ESM.docx (200 kb)
ESM 1 (DOCX 198 kb)

References

  1. 1.
    Mubagwa K, Flameng W (2001) Adenosine, adenosine receptors and myocardial protection: an updated overview. Cardiovasc Res 52(1):25–39Google Scholar
  2. 2.
    Cronstein BN (2011) Adenosine receptors and fibrosis: a translational review. F1000 Biol Rep 3:21.  https://doi.org/10.3410/B3-21 Google Scholar
  3. 3.
    Fredholm BB (2010) Adenosine receptors as drug targets. Exp Cell Res 316(8):1284–1288.  https://doi.org/10.1016/j.yexcr.2010.02.004 Google Scholar
  4. 4.
    Andine P, Rudolphi KA, Fredholm BB, Hagberg H (1990) Effect of propentofylline (HWA 285) on extracellular purines and excitatory amino acids in CA1 of rat hippocampus during transient ischaemia. Br J Pharmacol 100(4):814–818Google Scholar
  5. 5.
    Borea PA, Gassi S, Merighi S, Varani K (2016) Adenosine as a multi-signalling guardian angel in human diseases: when, where and how does it exert protective effects? Trends Pharmacol Sci 37(6):419–434Google Scholar
  6. 6.
    Feoktistov I, Biaggioni I, Cronstein BN (2009) Adenosine receptors in wound healing, fibrosis and angiogenesis. Handb Exp Pharmacol 193:383–397.  https://doi.org/10.1007/978-3-540-89615-9_13 Google Scholar
  7. 7.
    Berne RM, Belardinelli L (1985) Effects of hypoxia and ischaemia on coronary vascular resistance, A-V node conduction and S-A node excitation. Acta Medica Scand Suppl 694:9–19Google Scholar
  8. 8.
    Gawlowski DM, Duran WN (1986) Dose-related effects of adenosine and bradykinin on microvascular permselectivity to macromolecules in the hamster-cheek pouch. Circ Res 58(3):348–355Google Scholar
  9. 9.
    Des Rosiers C, Nees S (1987) Functional evidence for the presence of adenosine A2-receptors in cultured coronary endothelial cells. Naunyn Schmiedeberg's Arch Pharmacol 336(1):94–98Google Scholar
  10. 10.
    Bache RJ, Dai XZ, Schwartz JS, Homans DC (1988) Role of adenosine in coronary vasodilation during exercise. Circ Res 62(4):846–853Google Scholar
  11. 11.
    Meininger CJ, Schelling ME, Granger HJ (1988) Adenosine and hypoxia stimulate proliferation and migration of endothelial-cells. Am J Phys 255(3):H554–H562Google Scholar
  12. 12.
    Sun LL, Xu LL, Nielsen TB, Rhee P, Burris D (1999) Cyclopentyladenosine improves cell proliferation, wound healing, and hair growth. J Surg Res 87(1):14–24.  https://doi.org/10.1006/jsre.1999.5716 Google Scholar
  13. 13.
    Dana A, Baxter GF, Walker JM, Yellon DM (1998) Prolonging the delayed phase of myocardial protection: repetitive adenosine A1 receptor activation maintains rabbit myocardium in a preconditioned state. J Am Coll Cardiol 31(5):1142–1149Google Scholar
  14. 14.
    Carr CS, Hill RJ, Masamune H, Kennedy SP, Knight DR, Tracey WR, Yellon DM (1997) Evidence for a role for both the adenosine A1 and A3 receptors in protection of isolated human atrial muscle against simulated ischaemia. Cardiovasc Res 36(1):52–59Google Scholar
  15. 15.
    Stambaugh K, Jacobson KA, Jiang JL, Liang BT (1997) A novel cardioprotective function of adenosine A1 and A3 receptors during prolonged simulated ischemia. Am J Phys 273(1 Pt 2):H501–H505Google Scholar
  16. 16.
    Casati C, Forlani A, Lozza G, Monopoli A (1997) Hemodynamic changes do not mediate the cardioprotection induced by the A1, adenosine receptor agonist CCPA in the rabbit. Pharmacol Res 35(1):51–55.  https://doi.org/10.1006/phrs.1996.0114 Google Scholar
  17. 17.
    Olanrewaju HA, Mustafa SJ (1996) Effects of adenosine analogues on tension and cytosolic Ca2+ in porcine coronary artery. Am J Phys 270(1 Pt 2):H134–H141Google Scholar
  18. 18.
    Hasko G, Szabo C, Nemeth ZH, Kvetan V, Pastores SM, Vizi ES (1996) Adenosine receptor agonists differentially regulate IL-10, TNF-alpha, and nitric oxide production in RAW 264.7 macrophages and in endotoxemic mice. J Immunol 157(10):4634–4640Google Scholar
  19. 19.
    Schaffer MR, Fuchs N, Proksch B, Bongartz M, Beiter T, Becker HD (1998) Tacrolimus impairs wound healing: a possible role of decreased nitric oxide synthesis. Transplantation 65(6):813–818Google Scholar
  20. 20.
    Wallace HJ, Stacey MC (1998) Levels of tumor necrosis factor-α (TNF-α) and soluble TNF receptors in chronic venous leg ulcers–correlations to healing status. J Investig Dermatol 110(3):292–296Google Scholar
  21. 21.
    Chesney J, Metz C, Stavitsky AB, Bacher M, Bucala R (1998) Regulated production of type I collagen and inflammatory cytokines by peripheral blood fibrocytes. J Immunol 160(1):419–425Google Scholar
  22. 22.
    Montesinos MC, Desai A, Chen JF, Yee H, Schwarzschild MA, Fink JS, Cronstein BN (2002) Adenosine promotes wound healing and mediates angiogenesis in response to tissue injury via occupancy of A(2A) receptors. Am J Pathol 160(6):2009–2018.  https://doi.org/10.1016/s0002-9440(10)61151-0 Google Scholar
  23. 23.
    Montesinos MC, Gadangi P, Longaker M, Sung J, Levine J, Nilsen D, Reibman J, Li M, Jiang CK, Hirschhorn R, Recht PA, Ostad E, Levin RI, Cronstein BN (1997) Wound healing is accelerated by agonists of adenosine A2 (G alpha s-linked) receptors. J Exp Med 186(9):1615–1620Google Scholar
  24. 24.
    Palmer TM, Gettys TW, Stiles GL (1995) Differential interaction with and regulation of multiple G-proteins by the rat A3 adenosine receptor. J Biol Chem 270(28):16895–16902Google Scholar
  25. 25.
    Klinger M, Freissmuth M, Nanoff C (2002) Adenosine receptors: G protein-mediated signalling and the role of accessory proteins. Cell Signal 14(2):99–108Google Scholar
  26. 26.
    Headrick JP, Peart J (2005) A3 adenosine receptor-mediated protection of the ischemic heart. Vasc Pharmacol 42(5–6):271–279.  https://doi.org/10.1016/j.vph.2005.02.009 Google Scholar
  27. 27.
    Feoktistov I, Ryzhov S, Goldstein AE, Biaggioni I (2003) Mast cell-mediated stimulation of angiogenesis: cooperative interaction between A2B and A3 adenosine receptors. Circ Res 92(5):485–492.  https://doi.org/10.1161/01.RES.0000061572.10929.2D Google Scholar
  28. 28.
    Ansari HR, Nadeem A, Tilley SL, Mustafa SJ (2007) Involvement of COX-1 in A3 adenosine receptor-mediated contraction through endothelium in mice aorta. Am J Physiol Heart Circ Physiol 293:H3338–H3455Google Scholar
  29. 29.
    Zhao Z, Makaritsis K, Francis CE, Gavras H, Ravid K (2000) A role for the A3 adenosine receptor in determining tissue levels of cAMP and blood pressure: studies in knock-out mice. Biochim Biophys Acta 1500(3):280–290Google Scholar
  30. 30.
    Scientific T (2012) How to use a protein assay standard curveGoogle Scholar
  31. 31.
    Fredholm BB, AP IJ, Jacobson KA, Linden J, Muller CE (2011) International Union of Basic and Clinical Pharmacology. LXXXI. Nomenclature and classification of adenosine receptors--an update. Pharmacol Rev 63(1):1–34.  https://doi.org/10.1124/pr.110.003285 Google Scholar
  32. 32.
    Bouis D, Hospers GA, Meijer C, Molema G, Mulder NH (2001) Endothelium in vitro: a review of human vascular endothelial cell lines for blood vessel-related research. Angiogenesis 4(2):91–102Google Scholar
  33. 33.
    Edgell CJ, Haizlip JE, Bagnell CR, Packenham JP, Harrison P, Wilbourn B, Madden VJ (1990) Endothelium specific Weibel-Palade bodies in a continuous human cell line, EA.hy926. In Vitro Cell Dev Biol 26(12):1167–1172Google Scholar
  34. 34.
    Edgell CJ, McDonald CC, Graham JB (1983) Permanent cell line expressing human factor VIII-related antigen established by hybridization. Proc Natl Acad Sci U S A 80(12):3734–3737Google Scholar
  35. 35.
    Ethier MF, Chander V, Dobson JG Jr (1993) Adenosine stimulates proliferation of human endothelial cells in culture. Am J Phys 265(1 Pt 2):H131–H138Google Scholar
  36. 36.
    Ethier MF, Dobson JG Jr (1997) Adenosine stimulation of DNA synthesis in human endothelial cells. Am J Phys 272(3 Pt 2):H1470–H1479Google Scholar
  37. 37.
    Fredholm BB, AP IJ, Jacobson KA, Klotz KN, Linden J (2001) International Union of Pharmacology. XXV. Nomenclature and classification of adenosine receptors. Pharmacol Rev 53(4):527–552Google Scholar
  38. 38.
    Feoktistov I, Goldstein AE, Ryzhov S, Zeng D, Belardinelli L, Voyno-Yasenetskaya T, Biaggioni I (2002) Differential expression of adenosine receptors in human endothelial cells: role of A2B receptors in angiogenic factor regulation. Circ Res 90(5):531–538Google Scholar
  39. 39.
    Kim Y-C, Ji X-D, Melman N, Linden J, Jacobson KA (2000) Anilide derivatives of an 8-phenylxanthine carboxylic congener are highly potent and selective antagonists at human A2B adenosine receptors. J Med Chem 43:1165–1172Google Scholar
  40. 40.
    Baraldi PG, Tabrizi MA, Fruttarolo F, Romagnoli R, Preti D (2009) Recent improvements in the development of A2B adenosine receptor agonists. Purinergic Signal 5:3–19Google Scholar
  41. 41.
    Richter A, Hamann M (2001) Effects of adenosine receptor agonists and antagonists in a genetic animal model of primary paroxysmal dystonia. Br J Pharmacol 134(2):343–352.  https://doi.org/10.1038/sj.bjp.0704268 Google Scholar
  42. 42.
    Jonzon B, Nilsson J, Fredholm BB (1985) Adenosine receptor-mediated changes in cyclic AMP production and DNA synthesis in cultured arterial smooth muscle cells. J Cell Physiol 124(3):451–456.  https://doi.org/10.1002/jcp.1041240314 Google Scholar
  43. 43.
    Shaikh G, Cronstein B (2016) Signaling pathways involving adenosine A2A and A2B receptors in wound healing and fibrosis. Purinergic Signal 12(2):191–197.  https://doi.org/10.1007/s11302-016-9498-3 Google Scholar
  44. 44.
    Grant MB, Davis MI, Caballero S, Feoktistov I, Biaggioni I, Belardinelli L (2001) Proliferation, migration, and ERK activation in human retinal endothelial cells through A(2B) adenosine receptor stimulation. Invest Ophthalmol Vis Sci 42(9):2068–2073Google Scholar
  45. 45.
    Olanrewaju HA, Qin W, Feoktistov I, Scemama JL, Mustafa SJ (2000) Adenosine A(2A) and A(2B) receptors in cultured human and porcine coronary artery endothelial cells. Am J Phys Heart Circ Phys 279(2):H650–H656Google Scholar
  46. 46.
    Fischer S, Sharma HS, Karliczek GF, Schaper W (1995) Expression of vascular permeability factor/vascular endothelial growth factor in pig cerebral microvascular endothelial cells and its upregulation by adenosine. Brain Res Mol Brain Res 28(1):141–148Google Scholar
  47. 47.
    Grant MB, Tarnuzzer RW, Caballero S, Ozeck MJ, Davis MI, Spoerri PE, Feoktistov I, Biaggioni I, Shryock JC, Belardinelli L (1999) Adenosine receptor activation induces vascular endothelial growth factor in human retinal endothelial cells. Circ Res 85(8):699–706Google Scholar

Copyright information

© Springer Nature B.V. 2019

Authors and Affiliations

  • Zeinab Bonyanian
    • 1
  • Matthew Walker
    • 1
  • Eugene Du Toit
    • 1
  • Roselyn B. Rose’Meyer
    • 1
    Email author
  1. 1.School of Medical SciencesGriffith UniversityQueenslandAustralia

Personalised recommendations